Repros Therapeutics Inc Share Price

Stocks

27/18/27	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/17/16	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/17/13	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
12/17/12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/17/12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/15/02	Apple : Les valeurs à suivre sur les marchés américains
02/15/02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	-1.01%	+3.89%	+2.62%	+24.19%	5.17TCr
REVOLUTION MEDICINES, INC.	+1.92%	-0.26%	+503.98%	+550.09%	4.53TCr
IQVIA HOLDINGS INC.	+0.81%	+8.95%	+39.09%	+19.41%	4.27TCr
BEONE MEDICINES AG	-0.15%	+1.80%	+21.76%	+89.41%	4.28TCr
CELLTRION, INC.	-2.27%	-3.02%	+14.22%	+51.50%	3.29TCr
MEDPACE HOLDINGS, INC.	+0.81%	+4.87%	+32.62%	+138.26%	1.71TCr
ASCENDIS PHARMA A/S	-1.08%	+0.56%	-	-	1.66TCr
EUROFINS SCIENTIFIC SE	-1.70%	+4.54%	+9.11%	+30.36%	1.5TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.85%	+5.70%	+79.82%	+47.26%	1.42TCr
Average	-0.33%	+2.97%	+87.90%	+118.81%	3.09TCr
Weighted average by Cap.	-0.15%	+2.74%	+106.49%	+137.64%

Employees

Sector